化工儀器網(wǎng)手機(jī)版
移動(dòng)端訪問(wèn)更便捷杭州斯達(dá)特是一家集研發(fā)、生產(chǎn)、銷售與技術(shù)服務(wù)為一體的高科技生物公司,志在為全球體外診斷企業(yè)、生物制藥企業(yè)提供優(yōu)質(zhì)的抗體產(chǎn)品和抗體定制服務(wù),包括IVD抗原和抗體原料、精準(zhǔn)醫(yī)學(xué)診斷用抗體以及其他用途的免疫試劑整體解決方案。
查看更多化工儀器網(wǎng)手機(jī)版
移動(dòng)端訪問(wèn)更便捷
化工儀器網(wǎng)小程序
更多流量 更易傳播
公眾號(hào):chem17
隨時(shí)掌握行業(yè)動(dòng)態(tài)
| ¥1350 |
Starter/斯達(dá)特
生產(chǎn)廠家
S0I0004
748
浙江杭州市
2026/5/24 13:35:37
已通過(guò)化工儀器網(wǎng)認(rèn)證,請(qǐng)放心撥打
產(chǎn)品簡(jiǎn)介
Syndecan-1 (CD138) is mostly restricted to epithelia, and bears heparan sulfate chains that are capable of interacting with a large array of polypeptides, including extracellular matrix components and potent mediators of proliferation, adhesion and migration. For this reason, it has been studied extensively with respect to carcinomas and tumor progression. Frequently, but not always, syndecan-1 levels decrease as tumor grade, stage and invasiveness and dedifferentiation increase. However, in some tumors, levels of syndecan-1 increase, but the characterization of its distribution is relevant. There can be loss of membrane staining, but acquisition of cytoplasmic and/or nuclear staining that is abnormal. Moreover, the appearance of syndecan-1 in the tumor stroma, either associated with its cellular component or the collagenous matrix, is nearly always a sign of poor prognosis [PMID: 33921767].
The reagent can complete 50 slides for IHC experiment and the primary antibody is excessive.
關(guān)聯(lián)品牌
杭州斯達(dá)特是一家集研發(fā)、生產(chǎn)、銷售與技術(shù)服務(wù)為一體的高科技生物公司,志在為全球體外診斷企業(yè)、生物制藥企業(yè)提供優(yōu)質(zhì)的抗體產(chǎn)品和抗體定制服務(wù),包括IVD抗原和抗體原料、精準(zhǔn)醫(yī)學(xué)診斷用抗體以及其他用途的免疫試劑整體解決方案。
查看更多留言咨詢
移動(dòng)站:CD138 IHCstart Kit
您訪問(wèn)的CD138 IHCstart Kit產(chǎn)品信息,由杭州斯達(dá)特生物科技有限公司自行發(fā)布提供,產(chǎn)品價(jià)格為面議,如您想了解更多關(guān)于CD138 IHCstart Kit型號(hào)、參數(shù)、用途等信息,歡迎咨詢。
該內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布會(huì)員負(fù)責(zé),為保障安全,建議您在購(gòu)買相關(guān)產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)以及產(chǎn)品質(zhì)量!
相關(guān)分類
該廠商其他產(chǎn)品
相關(guān)技術(shù)文章
*您想獲取產(chǎn)品的資料:
個(gè)人信息:
用戶評(píng)論
發(fā)布評(píng)論